The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
95200476 9520047 6 F 2007 20160913 20130912 20160915 EXP US-009507513-1309USA003667 MERCK 0.00 F Y 59.86000 KG 20160915 LW US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
95200476 9520047 1 PS FOSAMAX ALENDRONATE SODIUM 1 Oral 70 MG, QW 20560 70 MG TABLET /wk
95200476 9520047 2 SS ALENDRONATE SODIUM. ALENDRONATE SODIUM 1 Oral 70 MG, QW 20560 70 MG TABLET /wk
95200476 9520047 3 SS ALENDRONATE SODIUM. ALENDRONATE SODIUM 1 Oral 70 MG, QW 0 70 MG /wk
95200476 9520047 4 SS ALENDRONATE SODIUM. ALENDRONATE SODIUM 1 Oral 70 MG, QW 0 70 MG /wk

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
95200476 9520047 1 Osteoporosis
95200476 9520047 2 Osteoporosis
95200476 9520047 3 Osteoporosis
95200476 9520047 4 Osteoporosis

Outcome of event

Event ID CASEID OUTC COD
95200476 9520047 DE
95200476 9520047 OT
95200476 9520047 HO
95200476 9520047 DS

Reactions reported

Event ID CASEID DRUG REC ACT PT
95200476 9520047 Arthralgia
95200476 9520047 Arthropathy
95200476 9520047 Back pain
95200476 9520047 Blood cholesterol increased
95200476 9520047 Blood glucose abnormal
95200476 9520047 Bursa disorder
95200476 9520047 Chest pain
95200476 9520047 Complication associated with device
95200476 9520047 Fall
95200476 9520047 Femur fracture
95200476 9520047 Hepatic cancer
95200476 9520047 Hypertonic bladder
95200476 9520047 Low turnover osteopathy
95200476 9520047 Lumbosacral radiculopathy
95200476 9520047 Lymphoma
95200476 9520047 Osteoarthritis
95200476 9520047 Post procedural infection
95200476 9520047 Sciatica
95200476 9520047 Skin ulcer
95200476 9520047 Small cell lung cancer metastatic
95200476 9520047 Spinal disorder
95200476 9520047 Supraventricular extrasystoles
95200476 9520047 Type V hyperlipidaemia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
95200476 9520047 1 2002 200803 0
95200476 9520047 2 200803 200807 0
95200476 9520047 3 200909 201005 0
95200476 9520047 4 201005 201101 0